{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T09:00:35Z","timestamp":1770973235367,"version":"3.50.1"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,30]],"date-time":"2024-09-30T00:00:00Z","timestamp":1727654400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100015107","name":"Cryptic Masons Medical Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015107","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","annalsofvascularsurgery.com","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Vascular Surgery"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.avsg.2024.08.004","type":"journal-article","created":{"date-parts":[[2024,9,27]],"date-time":"2024-09-27T06:29:47Z","timestamp":1727418587000},"page":"522-533","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"PA","title":["Allogenic Vertebral Body Adherent Mesenchymal Stromal Cells Promote Muscle Recovery in Diabetic Mouse Model of Limb Ischemia"],"prefix":"10.1016","volume":"110","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1523-5473","authenticated-orcid":false,"given":"Mackenzie K.","family":"Madison","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Theresa S.","family":"Doiron","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer","family":"Stashevsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nancy","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marlee","family":"Yancey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chang-Hyun","family":"Gil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanaa Dakour","family":"Aridi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erik J.","family":"Woods","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael P.","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven J.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.avsg.2024.08.004_bib1","doi-asserted-by":"crossref","first-page":"e875","DOI":"10.1161\/CIR.0000000000000967","article-title":"Reducing nontraumatic lower-extremity amputations by 20% by 2030: time to get to our feet: a policy statement from the American heart association","volume":"143","author":"Creager","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.avsg.2024.08.004_bib2","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1016\/j.jvs.2015.10.101","article-title":"Predictors of major amputation despite patent bypass grafts","volume":"63","author":"Smith","year":"2016","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.avsg.2024.08.004_bib3","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1056\/NEJMcp1709326","article-title":"Chronic limb-threatening ischemia","volume":"379","author":"Farber","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.avsg.2024.08.004_bib4","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1007\/s11886-018-1019-2","article-title":"Preventing major amputations in patients with critical limb ischemia","volume":"20","author":"Rudofker","year":"2018","journal-title":"Curr Cardiol Rep"},{"key":"10.1016\/j.avsg.2024.08.004_bib5","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/j.jvs.2006.06.023","article-title":"Autologous bone-marrow mononuclear cell implantation for patients with Rutherford grade II-III thromboangiitis obliterans","volume":"44","author":"Durdu","year":"2006","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.avsg.2024.08.004_bib6","doi-asserted-by":"crossref","first-page":"2679","DOI":"10.1161\/CIRCULATIONAHA.106.644203","article-title":"Unblinded pilot study of autologous transplantation of bone marrow mononuclear cells in patients with thromboangiitis obliterans","volume":"114","author":"Miyamoto","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.avsg.2024.08.004_bib7","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1016\/j.jvs.2011.01.074","article-title":"Autologous bone marrow mononuclear cell therapy is safe and promotes amputation-free survival in patients with critical limb ischemia","volume":"53","author":"Murphy","year":"2011","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.avsg.2024.08.004_bib8","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1038\/mt.2012.52","article-title":"Cellular therapy with Ixmyelocel-T to treat critical limb ischemia: the randomized, double-blind, placebo-controlled RESTORE-CLI trial","volume":"20","author":"Powell","year":"2012","journal-title":"Mol Ther"},{"key":"10.1016\/j.avsg.2024.08.004_bib9","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.jvs.2017.11.088","article-title":"Ethnic minorities with critical limb ischemia derive equal amputation risk reduction from autologous cell therapy compared with whites","volume":"68","author":"Wang","year":"2018","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.avsg.2024.08.004_bib10","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.2337\/dc16-0850","article-title":"Diabetes is associated with decreased limb survival in patients with critical limb ischemia: pooled data from two randomized controlled trials","volume":"39","author":"Spreen","year":"2016","journal-title":"Diabetes Care"},{"key":"10.1016\/j.avsg.2024.08.004_bib11","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1002\/sctm.18-0025","article-title":"Cell therapy for chronic limb-threatening ischemia: current evidence and future directions","volume":"7","author":"Teraa","year":"2018","journal-title":"Stem Cells Transl Med"},{"key":"10.1016\/j.avsg.2024.08.004_bib12","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1182\/bloodadvances.2017006205","article-title":"Immune dysfunctionality of replicative senescent mesenchymal stromal cells is corrected by IFNgamma priming","volume":"1","author":"Chinnadurai","year":"2017","journal-title":"Blood Adv"},{"key":"10.1016\/j.avsg.2024.08.004_bib13","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.jcyt.2020.07.003","article-title":"Identification and characterization of a large source of primary mesenchymal stem cells tightly adhered to bone surfaces of human vertebral body marrow cavities","volume":"22","author":"Johnstone","year":"2020","journal-title":"Cytotherapy"},{"key":"10.1016\/j.avsg.2024.08.004_bib14","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/165327","article-title":"Comparison of two new mouse models of polygenic type 2 diabetes at the Jackson laboratory, NONcNZO10Lt\/J and TALLYHO\/JngJ","volume":"2013","author":"Leiter","year":"2013","journal-title":"J Diabetes Res"},{"key":"10.1016\/j.avsg.2024.08.004_bib15","doi-asserted-by":"crossref","first-page":"2276","DOI":"10.1016\/j.bbadis.2019.05.004","article-title":"Molecular and cellular bases of diabetes: focus on type 2 diabetes mouse model-TallyHo","volume":"1865","author":"Tamarai","year":"2019","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"10.1016\/j.avsg.2024.08.004_bib16","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/978-1-62703-068-7_6","article-title":"The TALLYHO mouse as a model of human type 2 diabetes","volume":"933","author":"Kim","year":"2012","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.avsg.2024.08.004_bib17","doi-asserted-by":"crossref","first-page":"H877","DOI":"10.1152\/ajpheart.00772.2008","article-title":"Suppressed hindlimb perfusion in Rac2-\/- and Nox2-\/- mice does not result from impaired collateral growth","volume":"296","author":"Distasi","year":"2009","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.avsg.2024.08.004_bib18","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1111\/j.1476-5381.2012.01911.x","article-title":"The use of animal models in diabetes research","volume":"166","author":"King","year":"2012","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.avsg.2024.08.004_bib19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-1-59745-448-3_1","article-title":"Selecting the \"right\" mouse model for metabolic syndrome and type 2 diabetes research","volume":"560","author":"Leiter","year":"2009","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.avsg.2024.08.004_bib20","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1152\/japplphysiol.00987.2016","article-title":"Assessment of cardiac fibrosis: a morphometric method comparison for collagen quantification","volume":"122","author":"Schipke","year":"2017","journal-title":"J Appl Physiol (1985)"},{"key":"10.1016\/j.avsg.2024.08.004_bib21","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1159\/000235965","article-title":"Antioxidants reverse age-related collateral growth impairment","volume":"47","author":"Miller","year":"2010","journal-title":"J Vasc Res"},{"key":"10.1016\/j.avsg.2024.08.004_bib22","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1111\/febs.13827","article-title":"Regulatory T cells and skeletal muscle regeneration","volume":"284","author":"Schiaffino","year":"2017","journal-title":"FEBS J"},{"key":"10.1016\/j.avsg.2024.08.004_bib23","doi-asserted-by":"crossref","first-page":"2734","DOI":"10.1016\/j.biomaterials.2010.12.035","article-title":"Angiogenesis in ischemic tissue produced by spheroid grafting of human adipose-derived stromal cells","volume":"32","author":"Bhang","year":"2011","journal-title":"Biomaterials"},{"key":"10.1016\/j.avsg.2024.08.004_bib24","doi-asserted-by":"crossref","first-page":"657","DOI":"10.4196\/kjpp.2016.20.6.657","article-title":"Increasing injection frequency enhances the survival of injected bone marrow derived mesenchymal stem cells in a critical limb ischemia animal model","volume":"20","author":"Kang","year":"2016","journal-title":"Korean J Physiol Pharmacol"},{"key":"10.1016\/j.avsg.2024.08.004_bib25","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.jcyt.2015.10.013","article-title":"Mesenchymoangioblast-derived mesenchymal stromal cells inhibit cell damage, tissue damage and improve peripheral blood flow following hindlimb ischemic injury in mice","volume":"18","author":"Koch","year":"2016","journal-title":"Cytotherapy"},{"key":"10.1016\/j.avsg.2024.08.004_bib26","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1161\/CIRCULATIONAHA.109.898312","article-title":"Functional mesenchymal stem cells derived from human induced pluripotent stem cells attenuate limb ischemia in mice","volume":"121","author":"Lian","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.avsg.2024.08.004_bib27","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1080\/14653240902849762","article-title":"The role of placental-derived adherent stromal cell (PLX-PAD) in the treatment of critical limb ischemia","volume":"11","author":"Prather","year":"2009","journal-title":"Cytotherapy"},{"key":"10.1016\/j.avsg.2024.08.004_bib28","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1177\/0963689718784862","article-title":"Allogeneic mesenchymal stromal cells (MSCs) are of comparable efficacy to syngeneic MSCs for therapeutic revascularization in C57BKSdb\/db mice despite the induction of alloantibody","volume":"27","author":"Liew","year":"2018","journal-title":"Cell Transplant"},{"key":"10.1016\/j.avsg.2024.08.004_bib29","doi-asserted-by":"crossref","first-page":"260","DOI":"10.4062\/biomolther.2015.146","article-title":"Long-duration three-dimensional spheroid culture promotes angiogenic activities of adipose-derived mesenchymal stem cells","volume":"24","author":"Lee","year":"2016","journal-title":"Biomol Ther (Seoul)"},{"key":"10.1016\/j.avsg.2024.08.004_bib30","doi-asserted-by":"crossref","first-page":"9280","DOI":"10.1016\/j.biomaterials.2014.07.061","article-title":"Enhanced angiogenic effect of adipose-derived stromal cell spheroid with low-level light therapy in hind limb ischemia mice","volume":"35","author":"Park","year":"2014","journal-title":"Biomaterials"},{"key":"10.1016\/j.avsg.2024.08.004_bib31","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1161\/CIRCRESAHA.116.310535","article-title":"Four-dimensional microvascular analysis reveals that regenerative angiogenesis in ischemic muscle produces a flawed microcirculation","volume":"120","author":"Arpino","year":"2017","journal-title":"Circ Res"},{"key":"10.1016\/j.avsg.2024.08.004_bib32","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.avsg.2017.08.044","article-title":"Rationale and design of the ARREST trial investigating mesenchymal stem cells in the treatment of small abdominal aortic aneurysm","volume":"47","author":"Wang","year":"2018","journal-title":"Ann Vasc Surg"},{"key":"10.1016\/j.avsg.2024.08.004_bib33","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1089\/ars.2017.7420","article-title":"The role of metabolic remodeling in macrophage polarization and its effect on skeletal muscle regeneration","volume":"30","author":"De Santa","year":"2019","journal-title":"Antioxid Redox Signal"},{"key":"10.1016\/j.avsg.2024.08.004_bib34","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.ejvs.2014.12.010","article-title":"A new murine model of sustainable and durable chronic critical limb ischemia fairly mimicking human pathology","volume":"49","author":"Lejay","year":"2015","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.avsg.2024.08.004_bib35","doi-asserted-by":"crossref","first-page":"3991","DOI":"10.1007\/s11033-019-04844-1","article-title":"CKIP-1 regulates the immunomodulatory function of mesenchymal stem cells","volume":"46","author":"He","year":"2019","journal-title":"Mol Biol Rep"},{"key":"10.1016\/j.avsg.2024.08.004_bib36","doi-asserted-by":"crossref","DOI":"10.1145\/2818302","article-title":"Hypoxia pretreatment of bone marrow mesenchymal stem cells facilitates angiogenesis by improving the function of endothelial cells in diabetic rats with lower ischemia","volume":"10","author":"Liu","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.avsg.2024.08.004_bib37","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1186\/s13287-023-03439-9","article-title":"Physiological oxygen conditions enhance the angiogenic properties of extracellular vesicles from human mesenchymal stem cells","volume":"14","author":"Phelps","year":"2023","journal-title":"Stem Cell Res Ther"},{"key":"10.1016\/j.avsg.2024.08.004_bib38","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/s41536-024-00346-2","article-title":"Matrix-bound nanovesicle-associated IL-33 supports functional recovery after skeletal muscle injury by initiating a pro-regenerative macrophage phenotypic transition","volume":"9","author":"Bartolacci","year":"2024","journal-title":"NPJ Regen Med"},{"key":"10.1016\/j.avsg.2024.08.004_bib39","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.immuni.2016.01.009","article-title":"Poor repair of skeletal muscle in aging mice reflects a defect in local, interleukin-33-dependent accumulation of regulatory T cells","volume":"44","author":"Kuswanto","year":"2016","journal-title":"Immunity"}],"container-title":["Annals of Vascular Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890509624005582?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890509624005582?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,17]],"date-time":"2024-12-17T15:58:22Z","timestamp":1734451102000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0890509624005582"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":39,"alternative-id":["S0890509624005582"],"URL":"https:\/\/doi.org\/10.1016\/j.avsg.2024.08.004","relation":{},"ISSN":["0890-5096"],"issn-type":[{"value":"0890-5096","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Allogenic Vertebral Body Adherent Mesenchymal Stromal Cells Promote Muscle Recovery in Diabetic Mouse Model of Limb Ischemia","name":"articletitle","label":"Article Title"},{"value":"Annals of Vascular Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.avsg.2024.08.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}